3rd International Muscle-Bone Interaction in Duchenne Muscular Dystrophy Symposium

3 – 14 November 2022

Since the latest international standards of care for Duchenne Muscular Dystrophy (DMD) were published in 2018, which prompted greater emphasis on regular vertebral fracture monitoring and early treatment of bone morbidity, the landscape of DMD care has changed,. This symposium aims to review the evidence base that informed the 2018 international standards of care, best practices for implementation of these care considerations, and emerging knowledge that has arisen from research in the past two years.

The overall aim of this dialogue is to identify barriers to implementation of these “minimum standards of bone health care” worldwide, and to discuss future strategies that will move the dial on optimal management to foster bone strength and prevent fractures in this setting.

– Thursday 3rd November 2022 (17:00-20:00 GMT)
– Monday 14th November 2022 (17:00-20:00 GMT)


Further details

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern